The initial QuantiFERON-Lyme prototype is unsuitable for European patients
نویسندگان
چکیده
منابع مشابه
TAVI in Patients Unsuitable for Surgery
Since Alain Cribier performed the first human transcatheter aortic valve implantation (TAVI) in 2002 (1), the procedure has evolved into a reproducible and safe technique with >100,000 procedures performed worldwide. Early experience with new devices and techniques in Europe led to advanced procedural techniques, and large commercial and national registries provided real-world outcome data (2–4...
متن کاملCyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation.
As part of the randomized MRC Myeloma IX trial, we compared an attenuated regimen of cyclophosphamide, thalidomide, and dexamethasone (CTDa; n = 426) with melphalan and prednisolone (MP; n = 423) in patients with newly diagnosed multiple myeloma ineligible for autologous stem-cell transplantation. The primary endpoints were overall response rate, progression-free survival, and overall survival ...
متن کاملA Prototype Personalization System for the European Library Portal
In this demonstration, we present a flexible system that enables the provision of personalized functionalities to digital libraries. The system has been developed based on the needs of The European Library portal and will be demonstrated in that particular context, but could be applied more generally. It implements a broad set of data processing, analysis, and mining techniques over the portal’...
متن کاملA twist on Lyme: the challenge of diagnosing European Lyme neuroborreliosis.
Lyme neuroborreliosis is a tick-borne illness with central and peripheral nervous system manifestations. Clinical features and methods for accurate diagnosis differ across world regions owing to different causative Borrelia species. The importance of these distinctions is highlighted by a 12-year-old Canadian girl who acquired Lyme neuroborreliosis in Europe.
متن کاملProstate stent is an option for selected patients who are unsuitable for transurethral resection of the prostate.
INTRODUCTION Transurethral resection of the prostate (TUR-P) is the gold standard for treatment of severe lower urinary tract symptoms (LUTS) or urine retention. Some patients are unfit for surgery due to much co-morbidity and need alternative treatment. Intraprostatic stents are one example of minimally invasive treatment for LUTS. We present our results for 27 consecutive intraprostatic stent...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Infectious Diseases
سال: 2021
ISSN: 1058-4838,1537-6591
DOI: 10.1093/cid/ciab254